{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:09:23Z","timestamp":1788307763434,"version":"build-2803163510"},"reference-count":232,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"am","delay-in-days":392,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.vaccine.2023.02.009","type":"journal-article","created":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T21:31:53Z","timestamp":1676842313000},"page":"2357-2367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Vaccinomics: A scoping review"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1201-4066","authenticated-orcid":false,"given":"Matthew Z.","family":"Dudley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Budigan Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Blunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor A.","family":"Holroyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce C.","family":"Carleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Poland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.02.009_b0005","unstructured":"Ten great public health achievements--United States, 2001-2010. MMWR Morb Mortal Wkly Rep, 2011. 60 19 p. 619-23."},{"issue":"5","key":"10.1016\/j.vaccine.2023.02.009_b0010","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/S1473-3099(20)30130-4","article-title":"The state of vaccine safety science: systematic reviews of the evidence","volume":"20","author":"Dudley","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"15","key":"10.1016\/j.vaccine.2023.02.009_b0015","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.vaccine.2014.01.057","article-title":"The link between genetic variation and variability in vaccine responses: systematic review and meta-analyses","volume":"32","author":"Posteraro","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.02.009_b0020","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3389\/fimmu.2020.01181","article-title":"Current challenges in vaccinology","volume":"11","author":"Kennedy","year":"2020","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2023.02.009_b0025","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/sj.clpt.6100415","article-title":"Heterogeneity in vaccine immune response: The role of immunogenetics and the emerging field of vaccinomics","volume":"82","author":"Poland","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.vaccine.2023.02.009_b0030","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.clpt.6100379","article-title":"Pharmacology, vaccinomics, and the second golden age of vaccinology","volume":"82","author":"Poland","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2023.02.009_b0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/INF.0b013e3181a6a511","article-title":"Adversomics: the emerging field of vaccine adverse event immunogenetics","volume":"28","author":"Poland","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.009_b0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.smim.2013.04.007","article-title":"Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century","volume":"25","author":"Poland","year":"2013","journal-title":"Semin Immunol"},{"issue":"36","key":"10.1016\/j.vaccine.2023.02.009_b0045","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1016\/j.vaccine.2017.07.062","article-title":"Personalized vaccinology: a review","volume":"36","author":"Poland","year":"2018","journal-title":"Vaccine"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2023.02.009_b0050","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1016\/j.vaccine.2009.01.069","article-title":"Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics","volume":"27","author":"Poland","year":"2009","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2023.02.009_b0055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1089\/omi.2011.0032","article-title":"Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections","volume":"15","author":"Poland","year":"2011","journal-title":"OMICS"},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.009_b0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/gene.2017.1","article-title":"The immunogenetics of narcolepsy associated with A(H1N1)pdm09 vaccination (Pandemrix) supports a potent gene-environment interaction","volume":"18","author":"Bomfim","year":"2017","journal-title":"Genes Immun"},{"key":"10.1016\/j.vaccine.2023.02.009_b0065","unstructured":"Centers for Disease Control and Prevention. ACIP vaccine recommendations and guidelines. [cited 2020 April 2]; Available from: https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/index.html."},{"key":"10.1016\/j.vaccine.2023.02.009_b0070","unstructured":"Vaccine Adverse Event Reporting System. About VAERS. [cited 2020 April 2]; Available from: https:\/\/vaers.hhs.gov\/about.html."},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.009_b0075","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jclinepi.2015.01.001","article-title":"P < 5 \u00d7 10(-8) has emerged as a standard of statistical significance for genome-wide association studies","volume":"68","author":"Jannot","year":"2015","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"10.1016\/j.vaccine.2023.02.009_b0080","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1046\/j.1523-1755.1998.00909.x","article-title":"Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen","volume":"53","author":"Caillat-Zucman","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.vaccine.2023.02.009_b0085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.meegid.2018.06.006","article-title":"20mug hepatitis B vaccination reduced the risk of low responsiveness in infants with HLA-II risk genotype of HBsAg positive mothers","volume":"63","author":"Cao","year":"2018","journal-title":"Infect Genet Evol"},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.009_b0090","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.vaccine.2010.11.023","article-title":"Toll-like receptors and cytokines\/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine","volume":"29","author":"Chen","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2023.02.009_b0095","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/gene.2010.1","article-title":"New genetic associations detected in a host response study to hepatitis B vaccine","volume":"11","author":"Davila","year":"2010","journal-title":"Genes Immun"},{"issue":"41","key":"10.1016\/j.vaccine.2023.02.009_b0100","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1016\/j.vaccine.2014.07.064","article-title":"Genetic polymorphisms of CXCR5 and CXCL13 are associated with non-responsiveness to the hepatitis B vaccine","volume":"32","author":"Duan","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2023.02.009_b0105","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF02751531","article-title":"HLA tissue types in nonresponders to hepatitis B vaccine","volume":"63","author":"Durupinar","year":"1996","journal-title":"Indian J Pediatr"},{"issue":"7","key":"10.1016\/j.vaccine.2023.02.009_b0110","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/eji.1830220733","article-title":"Genetic control of nonresponsiveness to hepatitis B virus vaccine by an extended HLA haplotype","volume":"22","author":"Hatae","year":"1992","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2023.02.009_b0115","doi-asserted-by":"crossref","first-page":"e1898","DOI":"10.1371\/journal.pone.0001898","article-title":"Host genetic factors and vaccine-induced immunity to hepatitis B Virus Infection","volume":"3","author":"Hennig","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.02.009_b0120","first-page":"171","article-title":"Correlation between immunogenetic markers and \u201cin vivo\u201d response to the german hepatitis B vaccine","volume":"54","author":"Hoher","year":"1983","journal-title":"Dev Biol Stand"},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.009_b0125","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0198-8859(98)00014-7","article-title":"The influence of major histocompatibility complex class II genes and T-cell Vbeta repertoire on response to immunization with HBsAg","volume":"59","author":"Hohler","year":"1998","journal-title":"Hum Immunol"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2023.02.009_b0130","first-page":"481","article-title":"Titers of antibodies to the surface antigen of hepatitis B virus after vaccination in relation to immunity-related gene variants. a prospective study among hemodialysis patients. Pol","volume":"127","author":"Jodlowska-Siewert","year":"2017","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.vaccine.2023.02.009_b0135","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00439-009-0720-z","article-title":"Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth","volume":"126","author":"Li","year":"2009","journal-title":"Hum Genet"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2023.02.009_b0140","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1016\/j.vaccine.2008.04.038","article-title":"HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination","volume":"26","author":"Lin","year":"2008","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2023.02.009_b0145","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/jmv.24756","article-title":"Polymorphisms in IRG1 gene associated with immune responses to hepatitis B vaccination in a Chinese Han population and function to restrain the HBV life cycle","volume":"89","author":"Liu","year":"2017","journal-title":"J Med Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2023.02.009_b0150","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1399-0039.1989.tb01700.x","article-title":"HLA linked immune response to S and pre-S2 gene products in hepatitis B vaccination","volume":"33","author":"Marescot","year":"1989","journal-title":"Tissue Antigens"},{"issue":"6","key":"10.1016\/j.vaccine.2023.02.009_b0155","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0264-410X(94)00044-N","article-title":"Anti-HBV neonatal immunization with recombinant vaccine. Part II. molecular basis of the impaired alloreactivity","volume":"13","author":"Martinetti","year":"1995","journal-title":"Vaccine"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2023.02.009_b0160","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0264-410X(98)00389-2","article-title":"The influence of host factors and immunogenetics on lymphocyte responses to Hepagene vaccination","volume":"17","author":"McDermott","year":"1999","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b0165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1399-0039.1997.tb02827.x","article-title":"Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination","volume":"50","author":"McDermott","year":"1997","journal-title":"Tissue Antigens"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jmii.2013.01.004","article-title":"The role of human leukocyte antigen tissue groups in hepatitis B virus vaccination in Turkey","volume":"47","author":"Mert","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2023.02.009_b0175","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/hep.29876","article-title":"Key HLA-DRB1-DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine","volume":"68","author":"Nishida","year":"2018","journal-title":"Hepatology"},{"issue":"42","key":"10.1016\/j.vaccine.2023.02.009_b0180","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1016\/j.vaccine.2017.08.045","article-title":"Strong influence of human leukocyte antigen-DP variants on response to hepatitis B vaccine in a Japanese population","volume":"35","author":"Okada","year":"2017","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2023.02.009_b0185","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1016\/j.transproceed.2004.09.063","article-title":"The importance of A3 allele in response to hepatitis B vaccine in end-stage renal disease patients","volume":"36","author":"Ozdemir","year":"2004","journal-title":"Transplant Proc"},{"issue":"8","key":"10.1016\/j.vaccine.2023.02.009_b0190","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1093\/hmg\/ddt586","article-title":"A genome-wide association study identifies polymorphisms in the HLA-DR region associated with non-response to hepatitis B vaccination in Chinese Han populations","volume":"23","author":"Pan","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b0195","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jmv.22251","article-title":"Association between polymorphisms of the cytokine and cytokine receptor genes and immune response to hepatitis B vaccination in a Chinese Han population","volume":"84","author":"Pan","year":"2012","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.009_b0200","doi-asserted-by":"crossref","first-page":"e35303","DOI":"10.1371\/journal.pone.0035303","article-title":"CD3Z genetic polymorphism in immune response to hepatitis B vaccination in two independent Chinese populations","volume":"7","author":"Pan","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.009_b0205","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0272-6386(97)90036-6","article-title":"Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients","volume":"29","author":"Peces","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"19","key":"10.1016\/j.vaccine.2023.02.009_b0210","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1093\/hmg\/ddr302","article-title":"A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region","volume":"20","author":"Png","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.vaccine.2023.02.009_b0215","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0168-8278(90)90226-H","article-title":"Genetic basis of nonresponse to hepatitis B vaccine in hemodialyzed patients","volume":"11","author":"Pol","year":"1990","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.009_b0220","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.vaccine.2016.08.068","article-title":"Identification of amino acids in antigen-binding site of class II HLA proteins independently associated with hepatitis B vaccine response","volume":"35","author":"Sakai","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b0225","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-3083.1995.tb03626.x","article-title":"Relationship between the reactivity to hepatitis B virus vaccination and the frequency of MHC class I, II and III alleles in haemodialysis patients","volume":"42","author":"Stachowski","year":"1995","journal-title":"Scand J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.009_b0230","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1399-0039.1990.tb01757.x","article-title":"HLA-associated non-responsiveness to hepatitis B vaccine","volume":"35","author":"Varla-Leftherioti","year":"1990","journal-title":"Tissue Antigens"},{"issue":"5 Suppl","key":"10.1016\/j.vaccine.2023.02.009_b0235","doi-asserted-by":"crossref","first-page":"R188","DOI":"10.1007\/s004240000059","article-title":"The contribution of HLA-Class II antigens in humoral non-response and delayed response to HBsAG vaccination","volume":"440","author":"Vidan-Jeras","year":"2000","journal-title":"Pflugers Arch"},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.009_b0240","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/hep.20142","article-title":"HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination","volume":"39","author":"Wang","year":"2004","journal-title":"Hepatology"},{"issue":"43","key":"10.1016\/j.vaccine.2023.02.009_b0245","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.1016\/j.vaccine.2019.09.001","article-title":"Response to hepatitis B vaccination is co-determined by HLA-DPA1 and -DPB1","volume":"37","author":"Wang","year":"2019","journal-title":"Vaccine"},{"issue":"39","key":"10.1016\/j.vaccine.2023.02.009_b0250","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/j.vaccine.2012.07.010","article-title":"Association of polymorphisms of cytokine and TLR-2 genes with long-term immunity to hepatitis B in children vaccinated early in life","volume":"30","author":"Wang","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b0255","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0198-8859(88)90047-X","article-title":"Immune suppression gene on HLA-Bw54-DR4-DRw53 haplotype controls nonresponsiveness in humans to hepatitis B surface antigen via CD8+ suppressor T cells","volume":"22","author":"Watanabe","year":"1988","journal-title":"Hum Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.009_b0260","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1399-0039.1990.tb01802.x","article-title":"HLA-Bw54-DR4-DRw53-DQw4 haplotype controls nonresponsiveness to hepatitis-B surface antigen via CD8-positive suppressor T cells","volume":"36","author":"Watanabe","year":"1990","journal-title":"Tissue Antigens"},{"issue":"11","key":"10.1016\/j.vaccine.2023.02.009_b0265","doi-asserted-by":"crossref","first-page":"e022334","DOI":"10.1136\/bmjopen-2018-022334","article-title":"Association of IL-10 and IL-10RA single nucleotide polymorphisms with the responsiveness to HBV vaccination in Chinese infants of HBsAg(+)\/HBeAg(-) mothers: a nested case-control study","volume":"8","author":"Wen","year":"2018","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.vaccine.2023.02.009_b0270","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/jgh.12845","article-title":"SNP rs7770370 in HLA-DPB1 loci as a major genetic determinant of response to booster hepatitis B vaccination: results of a genome-wide association study","volume":"30","author":"Wu","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.vaccine.2023.02.009_b0275","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00439-013-1320-5","article-title":"Responses to booster hepatitis B vaccination are significantly correlated with genotypes of human leukocyte antigen (HLA)-DPB1 in neonatally vaccinated adolescents","volume":"132","author":"Wu","year":"2013","journal-title":"Hum Genet"},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.009_b0280","doi-asserted-by":"crossref","first-page":"e0149199","DOI":"10.1371\/journal.pone.0149199","article-title":"Deltex1 polymorphisms are associated with hepatitis B vaccination non-response in southwest china","volume":"11","author":"Xie","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.vaccine.2023.02.009_b0285","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/jmv.23934","article-title":"BTNL2 associated with the immune response to hepatitis B vaccination in a Chinese Han population","volume":"86","author":"Yang","year":"2014","journal-title":"J Med Virol"},{"issue":"43","key":"10.1016\/j.vaccine.2023.02.009_b0290","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1016\/j.vaccine.2014.08.007","article-title":"Association of HLA alleles with the responsiveness to hepatitis B virus vaccination in Korean infants","volume":"32","author":"Yoon","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2023.02.009_b0295","first-page":"433","article-title":"Genetic factors of low-responsiveness to hepatitis B virus vaccine confirms the importance of human leukocyte antigen class II types in a japanese young adult population","volume":"71","author":"Yukimasa","year":"2017","journal-title":"Acta Med Okayama"},{"issue":"11","key":"10.1016\/j.vaccine.2023.02.009_b0300","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1056\/NEJM198909143211103","article-title":"Genetic prediction of nonresponse to hepatitis B vaccine","volume":"321","author":"Alper","year":"1989","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b0305","doi-asserted-by":"crossref","first-page":"14","DOI":"10.11599\/germs.2016.1084","article-title":"IL-17 and IL-22 genetic polymorphisms in HBV vaccine non- and low-responders among healthcare workers","volume":"6","author":"Borzooy","year":"2016","journal-title":"Germs"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b0310","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12879-018-3166-x","article-title":"Mitogen-activated protein kinase eight polymorphisms are associated with immune responsiveness to HBV vaccinations in infants of HBsAg(+)\/HBeAg(-) mothers","volume":"18","author":"Cao","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2023.02.009_b0315","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7326\/0003-4819-105-3-356","article-title":"Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings","volume":"105","author":"Craven","year":"1986","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.vaccine.2023.02.009_b0320","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.gene.6363792","article-title":"Family study of non-responsiveness to hepatitis B vaccine confirms the importance of HLA class III C4A locus","volume":"2","author":"De Silvestri","year":"2001","journal-title":"Genes Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2023.02.009_b0325","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1586\/14760584.2014.962521","article-title":"Single nucleotide polymorphisms of vitamin D binding protein, vitamin D receptor and retinoid X receptor alpha genes and response to hepatitis B vaccination in renal replacement therapy patients","volume":"13","author":"Grzegorzewska","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2023.02.009_b0330","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cca.2012.03.004","article-title":"Effects of cytokine and cytokine receptor gene variation on high anti-HB titers: following up on Taiwan's neonatal hepatitis B immunization program","volume":"413","author":"Lin","year":"2012","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.vaccine.2023.02.009_b0335","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/clim.2000.4933","article-title":"Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond","volume":"97","author":"Martinetti","year":"2000","journal-title":"Clin Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.009_b0340","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0264-410X(98)00203-5","article-title":"Human leukocyte antigens influence the immune response to a pre-S\/S hepatitis B vaccine","volume":"17","author":"McDermott","year":"1999","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.vaccine.2023.02.009_b0345","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1016\/j.vaccine.2014.06.023","article-title":"Mannose-binding lectin and ficolin-2 do not influence humoral immune response to hepatitis B vaccine","volume":"32","author":"Osthoff","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b0350","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5604\/16652681.1226816","article-title":"Effects of interleukin-4 and interleukin-12B gene polymorphisms on hepatitis B virus vaccination","volume":"16","author":"Roh","year":"2017","journal-title":"Ann Hepatol"},{"issue":"5","key":"10.1016\/j.vaccine.2023.02.009_b0355","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1365-3083.2003.01256.x","article-title":"Analysis of T-cell receptor beta chain variable gene segment usage in healthy adult responders and nonresponders to recombinant hepatitis B vaccine","volume":"57","author":"Soroosh","year":"2003","journal-title":"Scand J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2023.02.009_b0360","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.4161\/hv.24938","article-title":"Association between microRNA polymorphisms and humoral immunity to hepatitis B vaccine","volume":"9","author":"Xiong","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2023.02.009_b0365","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1016\/S0264-410X(02)00267-0","article-title":"IL-1beta gene polymorphisms influence hepatitis B vaccination","volume":"20","author":"Yucesoy","year":"2002","journal-title":"Vaccine"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2023.02.009_b0370","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2152\/jmi.63.256","article-title":"Influence of single nucleotide polymorphisms of cytokine genes on anti-HBs antibody production after hepatitis B vaccination in a Japanese young adult population","volume":"63","author":"Yukimasa","year":"2016","journal-title":"J Med Invest"},{"issue":"6","key":"10.1016\/j.vaccine.2023.02.009_b0375","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1046\/j.1523-1755.2001.00062.x","article-title":"The interleukin-10 promoter genotype determines clinical immune function in hemodialysis patients","volume":"60","author":"Girndt","year":"2001","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b0380","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1038\/s41598-021-82986-8","article-title":"Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines","volume":"11","author":"Nishida","year":"2021","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.vaccine.2023.02.009_b0385","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/jvh.13168","article-title":"GWAS identifying HLA-DPB1 gene variants associated with responsiveness to hepatitis B virus vaccination in Koreans: Independent association of HLA-DPB1*04:02 possessing rs1042169 G - rs9277355 C - rs9277356 A","volume":"26","author":"Chung","year":"2019","journal-title":"J Viral Hepat"},{"issue":"3","key":"10.1016\/j.vaccine.2023.02.009_b0390","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/14760584.2020.1745637","article-title":"Polymorphism rs368234815 of interferon-\u03bb4 gene and generation of antibodies to hepatitis B virus surface antigen in extracorporeal dialysis patients","volume":"19","author":"Grzegorzewska","year":"2020","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2023.02.009_b0395","article-title":"Association of HLA-DPA1, HLA-DPB1, and HLA-DQB1 alleles with the long-term and booster immune responses of young adults vaccinated against the hepatitis B virus as neonates","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"issue":"30","key":"10.1016\/j.vaccine.2023.02.009_b0400","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.3748\/wjg.v24.i30.3347","article-title":"Host genetic factors affecting hepatitis B infection outcomes: insights from genome-wide association studies","volume":"24","author":"Akcay","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2023.02.009_b0405","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.scitotenv.2010.09.036","article-title":"Host genetic factors in hepatitis B infection, liver cancer and vaccination response: a review with a focus on Africa","volume":"423","author":"Hennig","year":"2012","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.vaccine.2023.02.009_b0410","unstructured":"Jafarzadeh A, et al., Human leukocyte antigens influence the antibody response to hepatitis B vaccine. 2015."},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.009_b0415","first-page":"139","article-title":"Influence of genetic factors on the susceptibility to HBV infection, its clinical pictures, and responsiveness to HBV vaccination","volume":"53","author":"Kacprzak-Bergman","year":"2005","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"1671","key":"10.1016\/j.vaccine.2023.02.009_b0420","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0341","article-title":"Searching for the human genetic factors standing in the way of universally effective vaccines","volume":"370","author":"Mentzer","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"12","key":"10.1016\/j.vaccine.2023.02.009_b0425","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.3748\/wjg.v13.i12.1770","article-title":"A comparative review of HLA associations with hepatitis B and C viral infections across global populations","volume":"13","author":"Singh","year":"2007","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.vaccine.2023.02.009_b0430","first-page":"9069375","article-title":"Clinical relevance of HLA Gene Variants in HBV Infection","author":"Wang","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2023.02.009_b0435","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3389\/fgene.2019.00696","article-title":"Host genetic determinants of hepatitis B virus infection","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Genet"},{"issue":"6","key":"10.1016\/j.vaccine.2023.02.009_b0440","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3748\/wjg.v19.i6.838","article-title":"Hepatitis B vaccine in celiac disease: yesterday, today and tomorrow","volume":"19","author":"Vitaliti","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.009_b0445","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00008480-199804000-00017","article-title":"The genetic basis for variation in antibody response to vaccines","volume":"10","author":"Poland","year":"1998","journal-title":"Curr Opin Pediatr"},{"issue":"11","key":"10.1016\/j.vaccine.2023.02.009_b0450","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9113561","article-title":"Vaccinomics and adversomics in the era of precision medicine: a review based on HBV, MMR, HPV, and COVID-19 Vaccines","volume":"9","author":"Omersel","year":"2020","journal-title":"J Clin Med"},{"issue":"14","key":"10.1016\/j.vaccine.2023.02.009_b0455","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/0264-410X(93)90173-U","article-title":"Association of HLA-DR14-DR52 with low responsiveness to hepatitis B vaccine in Chinese residents in Taiwan","volume":"11","author":"Hsu","year":"1993","journal-title":"Vaccine"},{"issue":"9338","key":"10.1016\/j.vaccine.2023.02.009_b0460","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(02)11083-X","article-title":"Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins","volume":"360","author":"Hohler","year":"2002","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.vaccine.2023.02.009_b0465","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.vaccine.2016.03.090","article-title":"Association of HLA-DP variants with the responsiveness to Hepatitis B virus vaccination in Korean Infants","volume":"34","author":"Roh","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.009_b0470","first-page":"92","article-title":"HLA-DRB1, DQA1 and DQB1 alleles and haplotypes frequencies in Iranian healthy adult responders and non-responders to recombinant hepatitis B vaccine","volume":"5","author":"Amirzargar","year":"2008","journal-title":"Iran J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.009_b0475","first-page":"308","article-title":"TH1 and TH2 responses are influenced by HLA antigens in healthy neonates vaccinated with recombinant hepatitis B vaccine","volume":"11","author":"Jafarzadeh","year":"2012","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2023.02.009_b0480","doi-asserted-by":"crossref","first-page":"e12273","DOI":"10.1371\/journal.pone.0012273","article-title":"Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysis","volume":"5","author":"Ryckman","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b0485","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/gene.2013.62","article-title":"HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy","volume":"15","author":"Wu","year":"2014","journal-title":"Genes Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.009_b0490","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/intimm\/8.4.525","article-title":"Contribution of HLA class I and class II alleles to the regulation of antibody production to hepatitis B surface antigen in humans","volume":"8","author":"Mineta","year":"1996","journal-title":"Int Immunol"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2023.02.009_b0495","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.cca.2011.01.006","article-title":"Serological surveillance and IL-10 genetic variants on anti-HBs titers: hepatitis B vaccination 20 years after neonatal immunization in Taiwan","volume":"412","author":"Lin","year":"2011","journal-title":"Clin Chim Acta"},{"issue":"40","key":"10.1016\/j.vaccine.2023.02.009_b0500","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1016\/j.vaccine.2013.06.108","article-title":"The effect of HLA on immunological response to hepatitis B vaccine in healthy people: a meta-analysis","volume":"31","author":"Li","year":"2013","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2023.02.009_b0505","doi-asserted-by":"crossref","first-page":"e24904","DOI":"10.1097\/MD.0000000000024904","article-title":"HLA-DPB1 alleles in hepatitis B vaccine response: a meta-analysis","volume":"100","author":"Ou","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.vaccine.2023.02.009_b0510","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1399-0039.1998.tb03001.x","article-title":"Response to hepatitis B vaccine: Multiple HLA genes are involved","volume":"51","author":"Desombere","year":"1998","journal-title":"Tissue Antigens"},{"issue":"3","key":"10.1016\/j.vaccine.2023.02.009_b0515","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0168-8278(02)00205-2","article-title":"C4A deficiency and nonresponse to hepatitis B vaccination","volume":"37","author":"Hohler","year":"2002","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.009_b0520","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1399-0039.1998.tb03058.x","article-title":"Haplotypes comprising subtypes of the DQB1*06 allele direct the antibody response after immunisation with hepatitis B surface antigen","volume":"52","author":"Lango-Warensjo","year":"1998","journal-title":"Tissue Antigens"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b0525","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1086\/338014","article-title":"Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine","volume":"185","author":"Gelder","year":"2002","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2023.02.009_b0530","doi-asserted-by":"crossref","first-page":"e71376","DOI":"10.1371\/journal.pone.0071376","article-title":"Correlation between human leukocyte antigen class II alleles and HAI titers detected post-influenza vaccination","volume":"8","author":"Moss","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.vaccine.2023.02.009_b0535","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.vaccine.2012.12.026","article-title":"Association of HLA class II genes with clinical hyporesponsiveness to trivalent inactivated influenza vaccine in children","volume":"31","author":"Narwaney","year":"2013","journal-title":"Vaccine"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2023.02.009_b0540","doi-asserted-by":"crossref","first-page":"D35","DOI":"10.1016\/j.vaccine.2008.07.065","article-title":"Immunogenetics of seasonal influenza vaccine response","volume":"26","author":"Poland","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b0545","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM197601012940104","article-title":"HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16","volume":"294","author":"Spencer","year":"1976","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.009_b0550","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/infdis\/jiw126","article-title":"Autoimmune Variant PTPN22 C1858T Is Associated With Impaired Responses to Influenza Vaccination","volume":"214","author":"Crabtree","year":"2016","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2023.02.009_b0555","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1086\/521370","article-title":"Host single-nucleotide polymorphisms and altered responses to inactivated influenza vaccine","volume":"196","author":"Tang","year":"2007","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b0560","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1080\/22221751.2020.1756696","article-title":"IFITM3 affects the level of antibody response after influenza vaccination","volume":"9","author":"Lei","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2023.02.009_b0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108440","article-title":"Higher PIK3C2B gene expression of H1N1+ specific B-cells is associated with lower H1N1 immunogenicity after trivalent influenza vaccination in HIV infected children","volume":"215","author":"Cotugno","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2023.02.009_b0570","first-page":"1944","article-title":"Efficacy of specific prevention of Influenza","volume":"73","author":"Pryimenko","year":"2020"},{"issue":"5","key":"10.1016\/j.vaccine.2023.02.009_b0575","first-page":"595","article-title":"Immune responses to killed influenza vaccine in patients with type 1 diabetes: altered responses associated with HLA-DR 3 and DR 4","volume":"112","author":"Ruben","year":"1988","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.vaccine.2023.02.009_b0580","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.664024","article-title":"Identification of two novel candidate genetic variants associated with the responsiveness to influenza vaccination","volume":"12","author":"Wen","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2023.02.009_b0585","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/21645515.2017.1338547","article-title":"Factors affecting immune responses to the influenza vaccine","volume":"14","author":"Castrucci","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.02.009_b0590","doi-asserted-by":"crossref","unstructured":"Nogales A, L.D M, Host Single Nucleotide Polymorphisms Modulating Influenza A Virus Disease in Humans. Pathogens, 2019. 8(4).","DOI":"10.3390\/pathogens8040168"},{"issue":"8","key":"10.1016\/j.vaccine.2023.02.009_b0595","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1586\/erv.12.61","article-title":"Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach","volume":"11","author":"Lambert","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.009_b0600","article-title":"\u201cGnothi Seauton\u201d: Leveraging the Host Response to Improve Influenza Virus Vaccine Efficacy","volume":"6","author":"Stacey","year":"2018","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"10.1016\/j.vaccine.2023.02.009_b0605","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00129785-200404050-00002","article-title":"Human genetics and responses to influenza vaccination: clinical implications","volume":"4","author":"Lambkin","year":"2004","journal-title":"Am J Pharmacogenomics"},{"key":"10.1016\/j.vaccine.2023.02.009_b0610","first-page":"1","article-title":"Factors influencing the immunogenicity of influenza vaccines","author":"Wen","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.009_b0615","article-title":"Mapping host-related correlates of influenza vaccine-induced immune response: an umbrella review of the available systematic reviews and meta-analyses","volume":"7","author":"Domnich","year":"2019","journal-title":"Vaccines (Basel)"},{"issue":"7","key":"10.1016\/j.vaccine.2023.02.009_b0620","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.vaccine.2013.12.009","article-title":"Leptin and leptin-related gene polymorphisms, obesity, and influenza A\/H1N1 vaccine-induced immune responses in older individuals","volume":"32","author":"Ovsyannikova","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.02.009_b0625","doi-asserted-by":"crossref","first-page":"20842","DOI":"10.1038\/srep20842","article-title":"IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity","volume":"6","author":"Avnir","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b0630","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1017\/S0022172400053365","article-title":"The effect of ABO blood groups on the incidence of epidemic influenza and on the response to live attenuated and detergent split influenza virus vaccines","volume":"80","author":"Mackenzie","year":"1978","journal-title":"J Hyg (Lond)"},{"issue":"12","key":"10.1016\/j.vaccine.2023.02.009_b0635","doi-asserted-by":"crossref","first-page":"e1004556","DOI":"10.1371\/journal.ppat.1004556","article-title":"IL-28B is a key regulator of B- and T-cell vaccine responses against influenza","volume":"10","author":"Egli","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2023.02.009_b0640","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fcimb.2018.00134","article-title":"High Level Antibody Response to Pandemic Influenza H1N1\/09 virus is associated with interferon-induced transmembrane protein-3 rs12252-CC in Young Adults","volume":"8","author":"Qin","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2023.02.009_b0645","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.vaccine.2012.01.025","article-title":"Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes","volume":"30","author":"Kennedy","year":"2012","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.vaccine.2023.02.009_b0650","doi-asserted-by":"crossref","first-page":"7883","DOI":"10.1016\/j.vaccine.2011.08.083","article-title":"Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination","volume":"29","author":"Haralambieva","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2023.02.009_b0655","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000331585","article-title":"The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms","volume":"72","author":"Ovsyannikova","year":"2011","journal-title":"Hum Hered"},{"issue":"11","key":"10.1016\/j.vaccine.2023.02.009_b0660","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00251-014-0796-z","article-title":"Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines","volume":"66","author":"Ovsyannikova","year":"2014","journal-title":"Immunogenetics"},{"issue":"14","key":"10.1016\/j.vaccine.2023.02.009_b0665","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.vaccine.2008.01.017","article-title":"Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results","volume":"26","author":"Dhiman","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.009_b0670","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00439-011-0977-x","article-title":"The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity","volume":"130","author":"Ovsyannikova","year":"2011","journal-title":"Hum Genet"},{"issue":"48","key":"10.1016\/j.vaccine.2023.02.009_b0675","doi-asserted-by":"crossref","first-page":"8988","DOI":"10.1016\/j.vaccine.2011.09.043","article-title":"Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine","volume":"29","author":"Haralambieva","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2023.02.009_b0680","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/CVI.05652-11","article-title":"CD46 measles virus receptor polymorphisms influence receptor protein expression and primary measles vaccine responses in naive Australian children","volume":"19","author":"Clifford","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2023.02.009_b0685","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jaci.2007.04.036","article-title":"Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors","volume":"120","author":"Dhiman","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.009_b0690","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00439-017-1768-9","article-title":"Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccine","volume":"136","author":"Haralambieva","year":"2017","journal-title":"Hum Genet"},{"issue":"12","key":"10.1016\/j.vaccine.2023.02.009_b0695","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.vaccine.2012.01.038","article-title":"Consistency of HLA associations between two independent measles vaccine cohorts: a replication study","volume":"30","author":"Ovsyannikova","year":"2012","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2023.02.009_b0700","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s00251-005-0061-6","article-title":"Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses","volume":"57","author":"Ovsyannikova","year":"2005","journal-title":"Immunogenetics"},{"issue":"19","key":"10.1016\/j.vaccine.2023.02.009_b0705","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0264-410X(98)00017-6","article-title":"The association between HLA class I alleles and measles vaccine-induced antibody response: evidence of a significant association","volume":"16","author":"Poland","year":"1998","journal-title":"Vaccine"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2023.02.009_b0710","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.vaccine.2003.11.016","article-title":"Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination","volume":"22","author":"Ovsyannikova","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b0715","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0198-8859(02)00741-3","article-title":"The association of class I HLA alleles and antibody levels after a single dose of measles vaccine","volume":"64","author":"Jacobson","year":"2003","journal-title":"Hum Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.009_b0720","doi-asserted-by":"crossref","first-page":"e0171261","DOI":"10.1371\/journal.pone.0171261","article-title":"A large population-based association study between HLA and KIR genotypes and measles vaccine antibody responses","volume":"12","author":"Ovsyannikova","year":"2017","journal-title":"PLoS One"},{"issue":"45","key":"10.1016\/j.vaccine.2023.02.009_b0725","doi-asserted-by":"crossref","first-page":"7982","DOI":"10.1016\/j.vaccine.2011.08.060","article-title":"Human leukocyte antigen associations with humoral and cellular immunity following a second dose of measles-containing vaccine: persistence, dampening, and extinction of associations found after a first dose","volume":"29","author":"Jacobson","year":"2011","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2023.02.009_b0730","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00251-004-0756-0","article-title":"HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine","volume":"56","author":"Ovsyannikova","year":"2005","journal-title":"Immunogenetics"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2023.02.009_b0735","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0264-410X(01)00346-2","article-title":"Identification of an association between HLA class II alleles and low antibody levels after measles immunization","volume":"20","author":"Poland","year":"2001","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2023.02.009_b0740","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1201-9712(98)90116-3","article-title":"Relationship of HLA-DQA1 alleles and humoral antibody following measles vaccination","volume":"2","author":"Hayney","year":"1998","journal-title":"Int J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2023.02.009_b0745","doi-asserted-by":"crossref","first-page":"e0160970","DOI":"10.1371\/journal.pone.0160970","article-title":"Whole transcriptome profiling identifies CD93 and other plasma cell survival factor genes associated with measles-specific antibody response after vaccination","volume":"11","author":"Haralambieva","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.vaccine.2023.02.009_b0750","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0039.2008.01097.x","article-title":"Associations between cytokine\/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population","volume":"72","author":"Dhiman","year":"2008","journal-title":"Tissue Antigens"},{"issue":"43","key":"10.1016\/j.vaccine.2023.02.009_b0755","doi-asserted-by":"crossref","first-page":"6180","DOI":"10.1016\/j.vaccine.2012.07.063","article-title":"Polymorphisms in key innate immune genes and their effects on measles vaccine responses and vaccine failure in children from Mozambique","volume":"30","author":"Clifford","year":"2012","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2023.02.009_b0760","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1086\/340573","article-title":"Associations between human leukocyte antigen homozygosity and antibody levels to measles vaccine","volume":"185","author":"St Sauver","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.02.009_b0765","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202049054","article-title":"Transcriptional signatures associated with rubella virus-specific humoral immunity after a third dose of MMR vaccine in women of childbearing age","author":"Haralambieva","year":"2021","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2023.02.009_b0770","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.humimm.2013.01.031","article-title":"Associations between polymorphisms in the antiviral TRIM genes and measles vaccine immunity","volume":"74","author":"Ovsyannikova","year":"2013","journal-title":"Hum Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2023.02.009_b0775","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1086\/500144","article-title":"Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine","volume":"193","author":"Ovsyannikova","year":"2006","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2023.02.009_b0780","first-page":"261","article-title":"The influence of the HLA-DRB1*13 allele on measles vaccine response","volume":"44","author":"Hayney","year":"1996","journal-title":"J Investig Med"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b0785","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1086\/510596","article-title":"Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes","volume":"195","author":"Dhiman","year":"2007","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2023.02.009_b0790","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1208\/s12248-011-9281-x","article-title":"Vaccinomics: current findings, challenges and novel approaches for vaccine development","volume":"13","author":"Ovsyannikova","year":"2011","journal-title":"Aaps j"},{"issue":"5","key":"10.1016\/j.vaccine.2023.02.009_b0795","doi-asserted-by":"crossref","first-page":"e1091","DOI":"10.1542\/peds.2007-1575","article-title":"Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine","volume":"121","author":"Ovsyannikova","year":"2008","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.009_b0800","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00251-010-0423-6","article-title":"SNP\/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine","volume":"62","author":"Dhiman","year":"2010","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2023.02.009_b0805","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2172-11-48","article-title":"Associations between SNPs in candidate immune-relevant genes and rubella antibody levels: a multigenic assessment","volume":"11","author":"Pankratz","year":"2010","journal-title":"BMC Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2023.02.009_b0810","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00439-014-1471-z","article-title":"Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination","volume":"133","author":"Kennedy","year":"2014","journal-title":"Hum Genet"},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.009_b0815","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00439-009-0763-1","article-title":"Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes","volume":"127","author":"Ovsyannikova","year":"2010","journal-title":"Hum Genet"},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.009_b0820","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1086\/649588","article-title":"Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination","volume":"201","author":"Ovsyannikova","year":"2010","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2023.02.009_b0825","doi-asserted-by":"crossref","first-page":"e99997","DOI":"10.1371\/journal.pone.0099997","article-title":"Associations between single nucleotide polymorphisms in cellular viral receptors and attachment factor-related genes and humoral immunity to rubella vaccination","volume":"9","author":"Haralambieva","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.009_b0830","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.humimm.2010.01.004","article-title":"2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine","volume":"71","author":"Haralambieva","year":"2010","journal-title":"Hum Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2023.02.009_b0835","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00251-015-0864-z","article-title":"Single nucleotide polymorphisms\/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children","volume":"67","author":"Ovsyannikova","year":"2015","journal-title":"Immunogenetics"},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.009_b0840","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/CVI.00247-06","article-title":"Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination","volume":"14","author":"Ovsyannikova","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2023.02.009_b0845","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1016\/j.vaccine.2009.01.079","article-title":"Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination","volume":"27","author":"Ovsyannikova","year":"2009","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.vaccine.2023.02.009_b0850","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1016\/j.vaccine.2014.04.091","article-title":"HLA genotypes and rubella vaccine immune response: additional evidence","volume":"32","author":"Ovsyannikova","year":"2014","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.009_b0855","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1086\/427558","article-title":"Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination","volume":"191","author":"Ovsyannikova","year":"2005","journal-title":"J Infect Dis"},{"issue":"49","key":"10.1016\/j.vaccine.2023.02.009_b0860","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1016\/j.vaccine.2009.08.109","article-title":"Replication of rubella vaccine population genetic studies: validation of HLA genotype and humoral response associations","volume":"27","author":"Ovsyannikova","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b0865","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13073-018-0568-8","article-title":"Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines","volume":"10","author":"Scepanovic","year":"2018","journal-title":"Genome Med"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2023.02.009_b0870","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00251-014-0776-3","article-title":"Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients","volume":"66","author":"Kennedy","year":"2014","journal-title":"Immunogenetics"},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.009_b0875","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/infdis\/jix538","article-title":"Polymorphisms in the Wilms Tumor Gene Are associated with interindividual variations in rubella virus-specific cellular immunity after measles-mumps-rubella II Vaccination","volume":"217","author":"Voigt","year":"2018","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2023.02.009_b0880","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.humimm.2005.03.008","article-title":"Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine","volume":"66","author":"St Sauver","year":"2005","journal-title":"Hum Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2023.02.009_b0885","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/infdis\/jiu553","article-title":"Polymorphisms in HLA-DPB1 are associated with differences in rubella virus-specific humoral immunity after vaccination","volume":"211","author":"Lambert","year":"2015","journal-title":"J Infect Dis"},{"issue":"29\u201330","key":"10.1016\/j.vaccine.2023.02.009_b0890","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1016\/j.vaccine.2008.05.011","article-title":"Gender-specific effects of cytokine gene polymorphisms on childhood vaccine responses","volume":"26","author":"Baynam","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.009_b0895","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaci.2006.09.018","article-title":"Parental smoking impairs vaccine responses in children with atopic genotypes","volume":"119","author":"Baynam","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"50","key":"10.1016\/j.vaccine.2023.02.009_b0900","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1016\/j.vaccine.2009.09.076","article-title":"Influence of cytokine gene variations on immunization to childhood vaccines","volume":"27","author":"Yucesoy","year":"2009","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.vaccine.2023.02.009_b0905","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1016\/j.vaccine.2018.09.041","article-title":"Tetanus-diphtheria vaccination in adults: the long-term persistence of antibodies is not dependent on polyclonal B-cell activation and the defective response to diphtheria toxoid re-vaccination is associated to HLADRB1 *01","volume":"36","author":"Ferlito","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2023.02.009_b0910","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/PSY.0b013e3180cc2c61","article-title":"Effects of chronic stress and interleukin-10 gene polymorphisms on antibody response to tetanus vaccine in family caregivers of patients with Alzheimer's disease","volume":"69","author":"Li","year":"2007","journal-title":"Psychosom Med"},{"issue":"46","key":"10.1016\/j.vaccine.2023.02.009_b0915","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1016\/j.vaccine.2013.09.026","article-title":"Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations","volume":"31","author":"Yucesoy","year":"2013","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2023.02.009_b0920","first-page":"311","article-title":"Immunoglobulin allotypes and response to tetanus toxoid in Papua","volume":"6","author":"Schanfield","year":"1979","journal-title":"New Guinea J Immunogenet"},{"issue":"10","key":"10.1016\/j.vaccine.2023.02.009_b0925","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1128\/CVI.00175-07","article-title":"Toll-like receptor 4 polymorphism associated with the response to whole-cell pertussis vaccination in children from the KOALA study","volume":"14","author":"Banus","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2023.02.009_b0930","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00251-016-0923-0","article-title":"Polymorphism of IL-10 gene promoter region: association with T cell proliferative responses after acellular pertussis vaccination in adults","volume":"68","author":"Grondahl-Yli-Hannuksela","year":"2016","journal-title":"Immunogenetics"},{"issue":"11","key":"10.1016\/j.vaccine.2023.02.009_b0935","doi-asserted-by":"crossref","first-page":"e3665","DOI":"10.1371\/journal.pone.0003665","article-title":"Association of interacting genes in the toll-like receptor signaling pathway and the antibody response to pertussis vaccination","volume":"3","author":"Kimman","year":"2008","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.vaccine.2023.02.009_b0940","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/infdis\/jis182","article-title":"Gene polymorphism in toll-like receptor 4: effect on antibody production and persistence after acellular pertussis vaccination during adolescence","volume":"205","author":"Grondahl-Yli-Hannuksela","year":"2012","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2023.02.009_b0945","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1086\/656236","article-title":"Association between single-nucleotide polymorphisms in Mal\/TIRAP and interleukin-10 genes and susceptibility to invasive haemophilus influenzae serotype b infection in immunized children","volume":"51","author":"Ladhani","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2023.02.009_b0950","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1172\/JCI111909","article-title":"Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria","volume":"75","author":"Ambrosino","year":"1985","journal-title":"J Clin Invest"},{"issue":"8109","key":"10.1016\/j.vaccine.2023.02.009_b0955","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0140-6736(79)90584-1","article-title":"Association between immunoglobulin allotypes and immune responses to Haemophilus influenzae and Meningococcus polysaccharides","volume":"1","author":"Pandey","year":"1979","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.009_b0960","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1542\/peds.2007-0524","article-title":"Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media","volume":"120","author":"Emonts","year":"2007","journal-title":"Pediatrics"},{"issue":"27","key":"10.1016\/j.vaccine.2023.02.009_b0965","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1016\/j.vaccine.2014.04.009","article-title":"Exonic single nucleotide polymorphisms within TLR3 associated with infant responses to serogroup C meningococcal conjugate vaccine","volume":"32","author":"O'Connor","year":"2014","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2023.02.009_b0970","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/j.celrep.2019.05.053","article-title":"Common Genetic Variations Associated with the Persistence of Immunity following Childhood Immunization","volume":"27","author":"O'Connor","year":"2019","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b0975","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1744-313X.1982.tb00779.x","article-title":"Immunoglobulin allotypes and immune response to meningococcal polysaccharides A and C","volume":"9","author":"Pandey","year":"1982","journal-title":"J Immunogenet"},{"issue":"3","key":"10.1016\/j.vaccine.2023.02.009_b0980","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1128\/CVI.05379-11","article-title":"Single nucleotide polymorphisms in the Toll-like receptor 3 and CD44 genes are associated with persistence of vaccine-induced immunity to the serogroup C meningococcal conjugate vaccine","volume":"19","author":"Moore","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.009_b0985","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.vaccine.2006.07.024","article-title":"Impact of genetic variants in IL-4, IL-4 RA and IL-13 on the anti-pneumococcal antibody response","volume":"25","author":"Wiertsema","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2023.02.009_b0990","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.vaccine.2005.08.029","article-title":"Pneumococcal vaccine efficacy for mucosal pneumococcal infections depends on Fcgamma receptor IIa polymorphism","volume":"24","author":"Wiertsema","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b0995","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clim.2003.12.005","article-title":"IgA deficiency: clinical correlates and responses to pneumococcal vaccine","volume":"111","author":"Edwards","year":"2004","journal-title":"Clin Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2023.02.009_b1000","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s00125-003-1157-x","article-title":"The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens","volume":"46","author":"Sadeharju","year":"2003","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b1005","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41598-018-19718-y","article-title":"The Lewis A phenotype is a restriction factor for Rotateq and Rotarix vaccine-take in Nicaraguan children","volume":"8","author":"Bucardo","year":"2018","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2023.02.009_b1010","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/infdis\/jix028","article-title":"Secretor and Salivary ABO blood group antigen status predict rotavirus vaccine take in infants","volume":"215","author":"Kazi","year":"2017","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2023.02.009_b1015","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/cid\/ciy1067","article-title":"Nonsecretor histo-blood group antigen phenotype is associated with reduced risk of clinical rotavirus vaccine failure in malawian infants","volume":"69","author":"Pollock","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"40","key":"10.1016\/j.vaccine.2023.02.009_b1020","doi-asserted-by":"crossref","first-page":"e12706","DOI":"10.1097\/MD.0000000000012706","article-title":"Association of human leukocyte antigen alleles and supertypes with immunogenicity of oral rotavirus vaccine given to infants in China","volume":"97","author":"Liu","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.vaccine.2023.02.009_b1025","doi-asserted-by":"crossref","DOI":"10.3390\/v12030324","article-title":"The Impact of Human Genetic Polymorphisms on Rotavirus Susceptibility, Epidemiology, and Vaccine Take","volume":"12","author":"Sharma","year":"2020","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.vaccine.2023.02.009_b1030","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/infdis\/jiy573","article-title":"Rotavirus Vaccine Take in Infants Is Associated With Secretor Status","volume":"219","author":"Armah","year":"2019","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2023.02.009_b1035","doi-asserted-by":"crossref","DOI":"10.3390\/v13061144","article-title":"Effect of infant and maternal secretor status on rotavirus vaccine take-an overview","volume":"13","author":"Sharma","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2023.02.009_b1040","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ebiom.2019.01.041","article-title":"Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival","volume":"40","author":"Hallberg","year":"2019","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.009_b1045","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/joim.12391","article-title":"A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009\u20132010 Pandemrix vaccination programme in Sweden","volume":"278","author":"Feltelius","year":"2015","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b1050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jneuroim.2014.08.134","article-title":"Genetic study of Pandemrix-associated narcolepsy","volume":"275","author":"Bomfim","year":"2014","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.009_b1055","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1212\/WNL.34.2.240","article-title":"HLA antigens in Guillain-Barre syndrome","volume":"34","author":"Kaslow","year":"1984","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.009_b1060","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102732","article-title":"Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: a study of 12 patients and a literature review","volume":"20","author":"Liozon","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.vaccine.2023.02.009_b1065","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.3129","article-title":"Common variants associated with general and MMR vaccine-related febrile seizures","volume":"46","author":"Feenstra","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2023.02.009_b1070","first-page":"1","article-title":"Genetic associations with a fever after measles-containing vaccines","author":"Klein","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"10.1016\/j.vaccine.2023.02.009_b1075","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/molbev\/mst080","article-title":"Evidence for polygenic adaptation to pathogens in the human genome","volume":"30","author":"Daub","year":"2013","journal-title":"Mol Biol Evol"},{"issue":"22","key":"10.1016\/j.vaccine.2023.02.009_b1080","doi-asserted-by":"crossref","first-page":"12288","DOI":"10.1073\/pnas.1922867117","article-title":"Polygenic risk for skin autoimmunity impacts immune checkpoint blockade in bladder cancer","volume":"117","author":"Khan","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.009_b1085","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s40615-016-0277-1","article-title":"If we would only ask: how henrietta lacks continues to teach us about perceptions of research and genetic research among african americans today","volume":"4","author":"Jones","year":"2017","journal-title":"J Racial Ethn Health Disparities"},{"issue":"6","key":"10.1016\/j.vaccine.2023.02.009_b1090","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S1474-4422(14)70075-4","article-title":"Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination","volume":"13","author":"Partinen","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.vaccine.2023.02.009_b1095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.smrv.2017.06.006","article-title":"Incidence of narcolepsy after H1N1 influenza and vaccinations: systematic review and meta-analysis","volume":"38","author":"Sarkanen","year":"2018","journal-title":"Sleep Med Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2023.02.009_b1100","doi-asserted-by":"crossref","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland","volume":"7","author":"Nohynek","year":"2012","journal-title":"PLoS One"},{"issue":"41","key":"10.1016\/j.vaccine.2023.02.009_b1105","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.1016\/j.vaccine.2018.08.008","article-title":"Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment","volume":"36","author":"Weibel","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.02.009_b1110","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f794","article-title":"Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine: retrospective analysis","volume":"346","author":"Miller","year":"2013","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.vaccine.2023.02.009_b1115","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.5665\/sleep.5752","article-title":"Risk of Narcolepsy after AS03 Adjuvanted Pandemic A\/H1N1 2009 influenza vaccine in adults: a case-coverage study in england","volume":"39","author":"Stowe","year":"2016","journal-title":"Sleep"},{"issue":"11","key":"10.1016\/j.vaccine.2023.02.009_b1120","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/dmcn.12522","article-title":"Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine in England","volume":"56","author":"Winstone","year":"2014","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"10.1016\/j.vaccine.2023.02.009_b1125","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/INF.0000000000002398","article-title":"Narcolepsy and pandemic influenza vaccination: what we need to know to be ready for the next pandemic","volume":"38","author":"Edwards","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b1130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4269\/ajtmh.19-0738","article-title":"Safety and Immunogenicity of an AS03(B)-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1\/2 Randomized Study","volume":"103","author":"Lin","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2023.02.009_b1135","doi-asserted-by":"crossref","first-page":"951","DOI":"10.4269\/ajtmh.19-0461","article-title":"Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: final results after 3 years of follow-up from a randomized, placebo-controlled phase I Study","volume":"102","author":"Diaz","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2023.02.009_b1140","unstructured":"Centers for Disease Control and Prevention. Different Types of Flu Vaccines. 2020 August 17 [cited 2020 September 3]; Available from: https:\/\/www.cdc.gov\/flu\/prevent\/different-flu-vaccines.htm."},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.009_b1145","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00281-018-0726-5","article-title":"Sex differences in vaccine-induced humoral immunity","volume":"41","author":"Fischinger","year":"2019","journal-title":"Semin Immunopathol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.009_b1150","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1542\/peds.2007-3021","article-title":"recommendations for pediatricians and medical homes\u2013implications for the system","volume":"121","author":"Newborn screening expands","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2023.02.009_b1155","series-title":"Policy implications of vaccinomics in the United States: community members' perspectives","author":"Gerber","year":"2020"},{"key":"10.1016\/j.vaccine.2023.02.009_b1160","series-title":"Public values and the policy implications of vaccinomics: results of a cross-sectional survey in the United States","author":"Gerber","year":"2020"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23001354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23001354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:24:43Z","timestamp":1759404283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23001354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":232,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0264410X23001354"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.02.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccinomics: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}